MedTrace Logo

Neuroliten MVP System Clinical Observation Study

NCT05520476 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-08-27

No results posted yet for this study

Summary

This is an observational study for data collection from subjects diagnosed with Epilepsy/intractable seizures. The Neuroliten MVP System will not be used for patient management or treatment decisions.

Conditions

Interventions

DEVICE

Neuroliten MVP system

The Neuroliten MVP system will be an App that gets uploaded to the patients iPhone from the App Store.

Sponsors & Collaborators

  • CSSi Life Sciences

    collaborator INDUSTRY

  • Enliten AI

    lead INDUSTRY

Principal Investigators

  • Barbara Hager, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2024-11-30
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05520476 on ClinicalTrials.gov